Craft

Centessa Pharmaceuticals

Stock Price

$15.4

2024-10-29

Market Capitalization

$2 B

2024-10-29

Revenue

$15 M

FY, 2025

Centessa Pharmaceuticals Summary

Company Summary

Overview
Centessa Pharmaceuticals is a biopharmaceutical company specializing in drug development. Its programs cover a range of high-value therapeutic areas including oncology, hematology, immunology / inflammation, neuroscience, hepatology, pulmonology, nephrology, and range from discovery-stage research through late-stage clinical development.
Type
Public
Status
Active
Founded
2021
HQ
Babraham, GB | view all locations
Website
https://www.centessa.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Babraham, England HQ

    United Kingdom

    The Dorothy Hodgkin Building Babraham Research, Campus

Centessa Pharmaceuticals Financials

Summary Financials

Net income (Q1, 2026)
($79.2M)
Cash (Q1, 2026)
$62.4M
EBIT (Q1, 2026)
($79.8M)
Enterprise value
$2.0B

Footer menu